Glaukos (GKOS) Profit After Tax (2014 - 2026)
Glaukos' (GKOS) quarterly Profit After Tax came in at -$19.8 million in Q1 2026, down 9.02% year-on-year from -$21.7 million in Q1 2025, and up 85.2% on a QoQ basis from -$133.7 million in Q4 2025.
Glaukos (GKOS) Profit After Tax (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Profit After Tax data on file, last reported at -$19.8 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 9.02% year-over-year to -$19.8 million in Q1 2026; TTM through Mar 2026 was -$189.3 million, a 53.08% decrease from a year earlier, with the FY2025 full-year figure at -$187.7 million, down 28.23% from the prior year.
- Profit After Tax for Q1 2026 stood at -$19.8 million, up from -$133.7 million in the prior quarter.
- Over the last five years, Profit After Tax for GKOS reached as high as $5.4 million in Q1 2022 and fell as low as -$133.7 million in Q4 2025.
- Historically, Profit After Tax has averaged -$34.6 million across 5 years, with a median of -$31.5 million in 2022.
- Across the five-year window, Profit After Tax jumped 132.65% in 2022 and plunged 743.97% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$31.5 million in 2022, then retreated by 16.91% to -$36.8 million in 2023, then advanced by 8.7% to -$33.6 million in 2024, then plunged by 298.03% to -$133.7 million in 2025, then jumped by 85.2% to -$19.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$19.8 million in Q1 2026, -$133.7 million in Q4 2025, and -$16.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | -19.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.78 Mn |
| Dec 31, 2025 | -133.66 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.15 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Sep 30, 2024 | -21.41 Mn |
| Jun 30, 2024 | -50.55 Mn |
| Mar 31, 2024 | -40.84 Mn |
| Dec 31, 2023 | -36.78 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.81 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | -31.46 Mn |
| Sep 30, 2022 | -27.58 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | -17.48 Mn |